Literature DB >> 11426030

Prediction of depression in systemic lupus erythematosus patients using SF-36 Mental Health scores.

T Stoll1, Y Kauer, S Büchi, R Klaghofer, T Sensky, P M Villiger.   

Abstract

OBJECTIVE: As depression is common in systemic lupus erythematosus (SLE) patients, we investigated whether and how the Medical Outcome Survey Short Form 36 (SF-36) scores, routinely used in the assessment of SLE patients, would indicate the absence or presence of depression.
METHODS: The Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D) and the SF-36 were applied in a cross-sectional cohort of 60 SLE patients [mean age 45 (S.D. 15) yr, disease duration 11 (9) yr, 90% female, 100% Caucasians]. The SF-36 domain score with the closest association with HADS-D was used for further analysis. On the basis of HADS-D scores, the patients were split into two groups: one without depression (score<8) and the other with possible depression (score > or =8).
RESULTS: The SF-36 Mental Health score was most closely correlated to the depression score (rho=-0.69, P<0.0005). The calculated Mental Health score cut-off value which significantly differentiated possibly depressed from non-depressed SLE patients was 61. Its sensitivity for the detection of possible depression was 89%, its specificity 77% and its negative predictive value 97%.
CONCLUSIONS: The present study contributes to knowledge of means of excluding depression and the prevention of underdiagnosis and undertreatment of depression in SLE patients.

Entities:  

Mesh:

Year:  2001        PMID: 11426030     DOI: 10.1093/rheumatology/40.6.695

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  12 in total

1.  Factorial validity and norm data comparison of the Short Form 12 in patients with inflammatory-rheumatic disease.

Authors:  Carsten Maurischat; Inge Ehlebracht-König; Alexander Kühn; Monika Bullinger
Journal:  Rheumatol Int       Date:  2005-09-23       Impact factor: 2.631

Review 2.  Quality-of-life measurements versus disease activity in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

3.  Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience.

Authors:  Zahra Zakeri; Mansoor Shakiba; Behzad Narouie; Nikol Mladkova; Mohammad Ghasemi-Rad; Alireza Khosravi
Journal:  Rheumatol Int       Date:  2011-01-21       Impact factor: 2.631

4.  The association of mental health over time with cardiac outcomes in HEMO study patients.

Authors:  Ea Wha Kang; Francis Pike; Sarah Ramer; Khaled Abdel-Kader; Larissa Myaskovsky; Mary Amanda Dew; Mark Unruh
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-05       Impact factor: 8.237

5.  [Speech impaired children. Anxiety, depression and quality of life of the mothers].

Authors:  M Rudolph; P Kummer; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2004-06       Impact factor: 1.284

6.  Predictors of self-reported health-related quality of life in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Vibeke Strand; Hong Fang; Jawali Jaranilla; Michelle Petri
Journal:  Rheumatology (Oxford)       Date:  2013-05-16       Impact factor: 7.580

Review 7.  The relationships between depression and brain tumors.

Authors:  N Scott Litofsky; Andrew G Resnick
Journal:  J Neurooncol       Date:  2009-03-05       Impact factor: 4.130

8.  Quality of life and satisfaction with life in SLE patients-the importance of clinical manifestations.

Authors:  Lilianna Kulczycka; Anna Sysa-Jedrzejowska; Ewa Robak
Journal:  Clin Rheumatol       Date:  2010-06-09       Impact factor: 2.980

9.  Assessing Depression among Older Persons with Arthritis: A Nationwide Health Status Survey.

Authors:  Rajesh Nayak; Jigar Rajpura
Journal:  ISRN Rheumatol       Date:  2013-07-15

10.  Physical function assessment tools in pediatric rheumatology.

Authors:  Lakshmi Nandini Moorthy; Margaret Ge Peterson; Melanie J Harrison; Karen B Onel; Thomas Ja Lehman
Journal:  Pediatr Rheumatol Online J       Date:  2008-06-04       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.